Form 8-K HALOZYME THERAPEUTICS, For: Oct 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SPY
9. SBUX
10. AXP

Go back to Form 8-K HALOZYME THERAPEUTICS, For: Oct 31

Halozyme Therapeutics (HALO) PT Raised to $58 at Leerink Partners

November 1, 2024 7:21 AM EDT

Leerink Partners analyst David Risinger raised the price target on Halozyme Therapeutics (NASDAQ: HALO) to $58.00 (from $56.00) while maintaining a Market Perform rating.

The analyst comments "Bottom line: We revised our model post-3Q results and bumped our DCF-derived PT from $56 to $58 (we... More